Literature DB >> 8589033

Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers.

F Dorion-Bonnet1, S Mautalen, I Hostein, M Longy.   

Abstract

The high incidence of allelic imbalance on the long arm of chromosome 16 in breast cancer suggests its involvement in the development and progression of the tumor. Several loss of heterozygosity (LOH) studies have led to the assignment of commonly deleted regions on 16q where tumor suppressor genes may be located. The most recurrent LOH regions have been 16q22.1 and 16q22.4-qter. The aim of this study was to gain further insight into the occurrence of one or multiple "smallest regions of overlap" on 16q in a new series of breast carcinomas. Hence, a detailed allelic imbalance map was constructed for 46 sporadic breast carcinomas, using 11 polymorphic microsatellite markers located on chromosome 16. Allelic imbalance of one or more markers on 16q was shown by 30 of the 46 tumors (65%). Among these 30 carcinomas, LOH on the long arm of chromosome 16 was detected at all informative loci in 19 (41%); 13 of them showed allelic imbalance on the long but not on the short arm, with the occurrence of variable "breakpoints" in the pericentromeric region. The partial allelic imbalance in 11 tumors involved either the 16q22.1-qter LOH region or interstitial LOH regions. A commonly deleted region was found between D16S421 and D16S289 on 16q22.1 in 29 of the 30 tumors. The present data argue in favor of an important involvement of a tumor suppressor gene mapping to 16q22.1 in the genesis or progression of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8589033     DOI: 10.1002/gcc.2870140304

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  A comprehensive study of chromosome 16q in invasive ductal and lobular breast carcinoma using array CGH.

Authors:  R Roylance; P Gorman; T Papior; Y-L Wan; M Ives; J E Watson; C Collins; N Wortham; C Langford; H Fiegler; N Carter; C Gillett; P Sasieni; S Pinder; A Hanby; I Tomlinson
Journal:  Oncogene       Date:  2006-05-15       Impact factor: 9.867

2.  Exclusion of BBC1 and CMAR as candidate breast tumour-suppressor genes.

Authors:  E Moerland; M H Breuning; C J Cornelisse; A M Cleton-Jansen
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Chromosome band 16q24 is frequently deleted in human gastric cancer.

Authors:  Y Mori; M Matsunaga; T Abe; S Fukushige; K Miura; M Sunamura; K Shiiba; M Sato; T Nukiwa; A Horii
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

4.  Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.

Authors:  H E Feilotter; V Coulon; J L McVeigh; A H Boag; F Dorion-Bonnet; B Duboué; W C Latham; C Eng; L M Mulligan; M Longy
Journal:  Br J Cancer       Date:  1999-02       Impact factor: 7.640

5.  Deletion mapping of chromosome 16q in hepatocellular carcinoma.

Authors:  Z Piao; C Park; J J Kim; H Kim
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

6.  Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3.

Authors:  A M Cleton-Jansen; E W Moerland; J C Pronk; C G van Berkel; S Apostolou; J Crawford; A Savoia; A D Auerbach; C G Mathew; D F Callen; C J Cornelisse
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

7.  Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour.

Authors:  R G Grundy; J Pritchard; P Scambler; J K Cowell
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

8.  A screen for germline mutations in the gene encoding CCCTC-binding factor (CTCF) in familial non-BRCA1/BRCA2 breast cancer.

Authors:  Xiao-Lei Zhou; Barbro Werelius; Annika Lindblom
Journal:  Breast Cancer Res       Date:  2004-03-09       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.